• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802892
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/16/2024
Event Type  malfunction  
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report a higher than expected vitros intact pth (ipth) result was obtained from a single patient sample when tested on a vitros xt 7600 integrated system.The result was discordant when compared to a non-vitros siemans atellica ipth result for a second sample from the same patient.Patient 1, ipth lot 1851, result of 111.00 pg/ml versus the expected result of 68.00 pg/ml biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The higher than expected vitros ipth result of 111.00 pg/ml was reported from the laboratory.However, no treatment was initiated, altered, or stopped based on the reported result.There was no allegation of patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4) and reportability assessment (b)(4).
 
Manufacturer Narrative
The investigation determined that a higher than expected vitros intact pth (ipth) result was obtained from a single patient sample when tested on a vitros xt 7600 integrated system.The result was discordant when compared to a non-vitros siemans atellica ipth result for a second sample from the same patient.A definitive assignable cause of the higher than expected vitros ipth result could not be determined.Based on historical quality control results, a vitros ipth lot 1851 performance issue is not a likely contributor to the event.Within run vitros tsh precision testing carried out indicated acceptable instrument performance approximately a month after the event, however, as no precision testing was carried out at the time of the event a transient instrument issue cannot be entirely ruled out as a contributing factor.The customer did not provide the pre-analytical sample handling protocol; therefore, it cannot be determined if the customer was following the sample collection device manufacture's recommendation for sample centrifugation, consequently, improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.It is possible an unknown interferent that affects the vitros ipth method and not the non-vitros siemans atellica method contributed to the event, however, this cannot be confirmed as the customer did not have any patient sample left for re-testing and the customer declined to call the patient back for additional testing.Additionally, as the patient was taking a number of different medications and suffers from a number of medical conditions, it is possible that the patient's clinical conditions and medications contributed to the higher than expected vitros ipth result.The vitros ipth instructions for use, other limitations sections states "certain drugs and clinical conditions are known to alter pth concentrations in vivo.For additional information, refer to one of the published summaries.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend NY CF35 5PZ
UK  CF35 5PZ
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key18920539
MDR Text Key337855552
Report Number3007111389-2024-00056
Device Sequence Number1
Product Code CEW
UDI-Device Identifier10758750006267
UDI-Public10758750006267
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number6802892
Device Lot Number1851
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/19/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/30/2023
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-